Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/JXX.0000000000000589 http://scihub22266oqcxt.onion/10.1097/JXX.0000000000000589 33767122!ä!33767122 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Am+Assoc+Nurse+Pract 2021 ; 34 (1): 8-11 Nephropedia Template TP {{tp|p=33767122|t=2021. Acute blood loss anemia after COVID-19 nasopharyngeal sampling |pdf=|usr=}}{{33767122}} gab.com Text Acute blood loss anemia after COVID-19 nasopharyngeal sampling JO: J Am Assoc Nurse Pract http://www.kidney.de/pget.php?&tw=1&pmid=33767122 #FOAvip Long-term care residents with novel coronavirus disease 2019 (COVID-19) experience high mortality rates and require frequent screening. Most resident testing occurs via nasopharyngeal swab that potentially causes epistaxis with rates of 5% to 8% in healthy populations. It is estimated that 48% of long-term care residents receive oral anticoagulation that increases risk of bleeding. A long-term care resident receiving oral anticoagulation experienced an episode of acute blood loss anemia after nasopharyngeal sampling. Current medications were not reviewed before testing, and oral anticoagulation was not held resulting in acute blood loss anemia. A medication review is indicated for skilled nursing and assisted living residents to identify oral anticoagulation before nasopharyngeal testing. Less invasive testing may be recommended or should bleeding occur, discontinuation of oral anticoagulation for a short term may be appropriate. Twit Text FOAVip Acute blood loss anemia after COVID-19 nasopharyngeal sampling ????J Am Assoc Nurse Pract http://www.kidney.de/pget.php?&tw=1&pmid=33767122 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33767122 #FOAvip English Wikipedia <ref>{{Cite pmid|33767122}}</ref> Acute blood loss anemia after COVID-19 nasopharyngeal sampling #MMPMID33767122 Watkins AK; Heinzman KM; Kurian TK; Hong M; Clark AP; Champion JD J Am Assoc Nurse Pract 2021[Mar]; 34 (1): 8-11 PMID33767122show ga Long-term care residents with novel coronavirus disease 2019 (COVID-19) experience high mortality rates and require frequent screening. Most resident testing occurs via nasopharyngeal swab that potentially causes epistaxis with rates of 5% to 8% in healthy populations. It is estimated that 48% of long-term care residents receive oral anticoagulation that increases risk of bleeding. A long-term care resident receiving oral anticoagulation experienced an episode of acute blood loss anemia after nasopharyngeal sampling. Current medications were not reviewed before testing, and oral anticoagulation was not held resulting in acute blood loss anemia. A medication review is indicated for skilled nursing and assisted living residents to identify oral anticoagulation before nasopharyngeal testing. Less invasive testing may be recommended or should bleeding occur, discontinuation of oral anticoagulation for a short term may be appropriate. |*Anemia/etiology[MESH] |*COVID-19[MESH] |Humans[MESH] |Medication Review[MESH] |Nasopharynx[MESH]Acute blood loss anemia after COVID-19 nasopharyngeal sampling (epmc).pdf DeepDyve Pubget Overpricing